EMA’s PRAC Recommends New Label Warnings for Several Products

International Pharmaceutical Regulatory Monitor
A A
The European Medicine Agency’s safety committee is recommending labeling changes for several products to cover newly identified risks of adverse events and side effects.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor